Clinical Trial Update: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating body weight–adjusted thyroxine therapy with triiodothyronine supplementation in secondary hypothyroidism and hypopituit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypopituitarism
• Hypothyroidism

Drugs mentioned

• Thyroxin (levothyroxine)
• Triiodothyronine (liothyronine sodium)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Secondary Hypothyroidism, Hypopituitarism | Phase 4 | Status: COMPLETED